A Case of Idiopathic Thrombocytopenic Purpura with Anti-E Antibody Developed after Transfusion of Platelet Concentrates
暂无分享,去创建一个
Jin-Yeong Han | K. Kim | Jae-Ho Yoo | K. Kim | J. Kim
[1] B. Michalewska,et al. Acute haemolytic transfusion reaction apparently caused by the ‘enzyme‐only’ anti‐E , 2005, Vox sanguinis.
[2] Edward J. Lee,et al. Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. , 2005, Blood.
[3] M. Lozano,et al. Risk of Rh(D) alloimmunization after transfusion of platelets from D+ donors to D– recipients , 2005, Transfusion.
[4] D. Dwyre,et al. A red blood cell autoantibody with mimicking anti‐E specificity , 2004, Transfusion.
[5] S. Sloan,et al. Platelet transfusion in an infant leading to formation of anti‐D: implications for immunoprophylaxis , 2004, Transfusion.
[6] S. Joy,et al. Management of Pregnancies Complicated by Anti-E Alloimmunization , 2003, Obstetrics and gynecology.
[7] I. Roberti,et al. Severe Acute Renal Failure Due to Hemoglobinuria After Use of WinRho for the Treatment of Idiopathic Thrombocytopenic Purpura , 2001, Clinical pediatrics.
[8] C. Parker. Intravenous Rh(o) [D] immune globulin [human] (WinRho SDF): suspected hemolytic/renal adverse reactions. , 2000, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[9] M. Hołub,et al. Case report: passively acquired anti-D in a D+ pregnant patient , 1999, Immunohematology.
[10] R. Ware,et al. Immunologic effects of anti‐D (WinRho‐SD) in children with immune thrombocytopenic purpura , 1998, American journal of hematology.
[11] R. Strauss,et al. Multiple transfusions fail to provoke antibodies against blood cell antigens in human infants , 1986, Transfusion.
[12] J. Cid,et al. The clinical implications of platelet transfusions associated with ABO or Rh(D) incompatibility. , 2003, Transfusion medicine reviews.
[13] F. Malinoski,et al. Safety profile of WinRho anti-D. , 1998, Seminars in hematology.
[14] D. Mauger,et al. Efficacy, safety, and dose response of intravenous anti-D immune globulin (WinRho SDF) for the treatment of idiopathic thrombocytopenic purpura in children. , 1998, Seminars in hematology.